Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Гипотензивная терапия: новая комбинация и новые возможности
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. ESH/ESC Guidelines for the managementof arterial hypertension, 2013.
2. Poon IO. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 2008; 28 (3): 366–75.
3. Epstein M. Lercanidipine: a novel dihydropyridine calcium-channel blocker. Heart Dis 2001; 3 (6): 398–407.
4. McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs 2000; 60 (5): 1123–40.
5. Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 2003; 63 (22): 2449–72.
6. Farah R, Khamisy-Farah R, Shurtz-Swirski R. Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients. Int Angiol 2013; 32 (1): 85–93.
7. Cicero AF, Gerocarni B, Rosticci M, Borghi C. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Clin Exp Hypertens 2012; 34 (2): 113–7.
8. Borghi C, Cicero AF. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clin Drug Investig 2010; 30 (12): 843–54.
9. Hair PI, Scott LJ, Perry CM. Fixed-dose combination lercanidipine/enalapril. Drugs 2007; 67 (1): 95–106; discussion 107–8.
10. Rump LC. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension. Arzneimittelforschung 2010; 60 (3): 124–30.
11. Scholze J, Bramlage P, Trenkwalder P, Kreutz R. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure. Expert Opin Pharmacother 2011; 12 (18): 2771–9.
12. Egan CG, Pontremoli R. Role of the fixed-dose combination lercanidipine-enalapril in renal protection. J Nephrol 2011; 24 (4): 428–37.
2. Poon IO. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Pharmacotherapy 2008; 28 (3): 366–75.
3. Epstein M. Lercanidipine: a novel dihydropyridine calcium-channel blocker. Heart Dis 2001; 3 (6): 398–407.
4. McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs 2000; 60 (5): 1123–40.
5. Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 2003; 63 (22): 2449–72.
6. Farah R, Khamisy-Farah R, Shurtz-Swirski R. Calcium channel blocker effect on insulin resistance and inflammatory markers in essential hypertension patients. Int Angiol 2013; 32 (1): 85–93.
7. Cicero AF, Gerocarni B, Rosticci M, Borghi C. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Clin Exp Hypertens 2012; 34 (2): 113–7.
8. Borghi C, Cicero AF. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clin Drug Investig 2010; 30 (12): 843–54.
9. Hair PI, Scott LJ, Perry CM. Fixed-dose combination lercanidipine/enalapril. Drugs 2007; 67 (1): 95–106; discussion 107–8.
10. Rump LC. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension. Arzneimittelforschung 2010; 60 (3): 124–30.
11. Scholze J, Bramlage P, Trenkwalder P, Kreutz R. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure. Expert Opin Pharmacother 2011; 12 (18): 2771–9.
12. Egan CG, Pontremoli R. Role of the fixed-dose combination lercanidipine-enalapril in renal protection. J Nephrol 2011; 24 (4): 428–37.
Авторы
Е.А.Прохорович
Кафедра терапии, клинической фармакологии и скорой медицинской помощи ГБОУ ВПО МГМСУ им. А.И.Евдокимова
Кафедра терапии, клинической фармакологии и скорой медицинской помощи ГБОУ ВПО МГМСУ им. А.И.Евдокимова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.